Yanling Wang

Yanling Wang has a diverse work experience in the field of scientific research. Starting in 2010, they worked as a Postdoctoral at the University of Pennsylvania Perelman School of Medicine, focusing on the functional characterization of microRNAs in ovarian and breast cancers. In 2014, they continued as a Postdoctoral, studying the role of endothelial cells in tumor microenvironments and T cell migration in solid tumors. In 2019, they transitioned to a Research Associate role at the same institution. In 2020, they joined Legend Biotech as a Scientist II. Currently, Yanling Wang is a Senior Scientist at Tmunity Therapeutics Incorporated as of January 2022.

Yanling Wang started their education at Lanzhou University in 1998 and obtained a Bachelor's degree in Biology/Biological Sciences, General in 2002. Yanling then pursued a Master's degree in Immunology at Lanzhou University from 2002 to 2005. Subsequently, they joined the Chinese Academy of Sciences and completed their Doctor of Philosophy - PhD in Oncology and Cancer Biology from 2006 to 2009.